By restricting high risk patients (the denominator) to individuals with high insulin levels rather than the general population, WHO and EGIR criteria identifies only insulin resistant individuals with the metabolic syndrome and misses many individuals who are at increased risk of cardiovascular disease, but without elevated insulin levels. The gene discussed is INS; the disease is cardiovascular disorder.